Brazilian lung cancer study aims to bridge treatment gaps
NCT ID NCT07109154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the real-world treatment of advanced non-small cell lung cancer (NSCLC) in Brazil. Researchers will review medical records of 200 patients and survey doctors to see if treatments follow national guidelines. The goal is to understand patient demographics and improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with advanced non-small cell lung carcinoma, treated in one of the seven centers selected, between January 2025 and January 2026.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Advanced (unresectable or metastatic) non-small cell lung carcinoma * First-line oncological treatment in one of the participating centers between 2025 and 2026 (between January 2025 and January 2026) * \> 18 years old * Data available in electronic medical records. Exclusion Criteria: * Localized disease amenable to local treatment * Non-epithelial histology * Small cell carcinoma * Neuroendocrine tumor * Patients with unresectable NSCLC who underwent treatment with the PACIFIC protocol and are being followed up.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced non-small cell lung carcinoma are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
5 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Research Site
ACTIVE_NOT_RECRUITINGRecife, Brazil
-
Research Site
RECRUITINGRio de Janeiro, Brazil
-
Research Site
NOT_YET_RECRUITINGRio de Janeiro, Brazil
-
Research Site
RECRUITINGSalvador, Brazil
-
Research Site
NOT_YET_RECRUITINGSalvador, Brazil
-
Research Site
ACTIVE_NOT_RECRUITINGSão Paulo, Brazil
-
Research Site
NOT_YET_RECRUITINGSão Paulo, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which nerve block wins for lung surgery pain?
- Radiation and immunotherapy combo tested against advanced lung cancer
- Radioactive antibody aims to light up hidden solid tumors
- AI trained to tell dangerous lung nodules from harmless ones
- AI reads tumor slides to match cancer patients with trials
- Magnetic pulses to the brain may help lung cancer patients sleep after surgery